In pancreatic tumors, a comprehensive proteomic study identified the C4b-binding protein α-chain (C4BPA) as a novel serum biomarker, showing promise for early stage PDAC detection and differentiation from other gastroenterological cancers [62]. Here, C4BPA is linked to pancreatic neoplasm.